ESSA PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.98 USD | +1.45% |
|
+13.68% | +5.76% |
| 03-06 | Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call | |
| 03-06 | Norway's wealth fund pushes for more women on emerging market company boards | RE |
Chart calendar ESSA Pharma Inc.
94046.RKnl9jxk65DIGkTA2DzU5mKCkO5uJ38N4N8hjXsgYhQ.Af2jhFUjg8iZammj6FOwrFP7wt8kTElBh6pq7yttOn4g07KncQq8_Y19Iw~18bcf9687a0fb5dd75207f5f7ae1d9cc
Upcoming events on ESSA Pharma Inc.
Past events on ESSA Pharma Inc.
| Today | Q2 2024 Earnings Release (Projected) |
| 16/04/2024 19:30 | Bloom Burton & Co. Healthcare Investor Conference |
| 06/03/2024 22:00 | Annual General Meeting |
| 13/02/2024 17:40 | Oppenheimer Healthcare Life Sciences Conference |
| 13/02/2024 12:00 | Q1 2024 Earnings Release |
| 25/01/2024 19:30 | ASCO Genitourinary Cancers Symposium - Abstract #: 141 |
| 12/12/2023 12:08 | Q4 2023 Earnings Release |
| 30/11/2023 17:00 | Piper Sandler Healthcare Conference |
| 15/11/2023 08:30 | Jefferies London Healthcare Conference |
| 27/10/2023 03:30 | Prostate Cancer Foundation Scientific Retreat Conference - Andrew Laccetti |
| 21/10/2023 | European Society for Medical Oncology Congress - Poster No: 1813P |
| 08/08/2023 12:00 | Q3 2023 Earnings Release |
| 08/06/2023 13:00 | Jefferies Global Healthcare Conference |
| 16/05/2023 15:00 | JMP Securities Life Sciences Conference |
| 09/05/2023 12:00 | Q2 2023 Earnings Release |
| 25/04/2023 19:00 | Bloom Burton & Co Healthcare Investor Conference |
| 15/03/2023 15:20 | Oppenheimer Healthcare Conference |
| 09/03/2023 22:00 | Annual General Meeting |
| 15/02/2023 | American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract #177 |
| 15/02/2023 | American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract #179 |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -16,7 -17,2 2.5% | -30,6 -34,6 11.67% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million CAD | Released Forecast Spread | -16,8 -17,2 2.64% | -30,7 -33,4 7.97% | -46,8 -47,7 1.81% | -50,5 -57,6 12.32% | -43,6 -47,7 8.65% | -54,3 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -13,7 -17,1 20.24% | -30,2 -32,9 8.05% | -46,4 -47,6 2.54% | -48,1 -55,9 13.93% | -36,1 -42,2 14.46% | -47,5 |
|
Net income Million CAD | Released Forecast Spread | -13,7 -17,1 19.95% | -29,9 -32,7 8.71% | -46,4 -47,6 2.59% | -48,0 -55,9 14.14% | -36,1 -42,2 14.46% | -47,5 |
|
EPS CAD | Released Forecast Spread | -1,63 -1,77 7.87% | -1,32 -1,44 8.34% | -1,21 -1,29 5.94% | -1,09 -1,22 10.58% | -0,81 -0,95 14.4% | -1,07 |
| Announcement Date | 19/12/19 | 15/12/20 | 18/11/21 | 13/12/22 | 12/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million CAD | Released Forecast Spread | -11,5 -12,5 7.67% | -14,9 -14,7 -1.07% | -11,9 -15,4 22.48% | -9,73 -17,7 44.87% | -10,6 -15,3 30.82% | -11,0 -12,7 13.64% | -11,9 -12,1 1.71% | -9,70 -13,6 28.67% | -10,2 -11,7 13.06% | -12,6 | -14,5 | -17,0 | -25,8 | -29,8 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -11,5 -12,6 8.24% | -14,1 -14,3 1.58% | -11,4 -15,4 25.71% | -8,73 -16,9 48.27% | -9,06 -13,8 34.13% | -9,43 -12,3 23.11% | -9,77 -11,8 17.14% | -7,44 -13,3 43.89% | -8,02 -10,3 22.4% | -11,2 | -12,9 | -15,3 | -25,8 | -29,8 |
|
Net income Million CAD | Released Forecast Spread | -11,5 -12,6 8.24% | -14,1 -14,3 1.58% | -11,3 -15,4 26.1% | -8,64 -16,9 48.8% | -9,06 -13,8 34.16% | -9,43 -12,3 23.04% | -9,77 -11,6 15.88% | -7,44 -13,2 43.81% | -8,02 -10,3 22.27% | -11,2 | -12,9 | -15,3 | -25,8 | -29,8 |
|
EPS CAD | Released Forecast Spread | -0,27 -0,29 8.53% | -0,32 -0,32 -0.92% | -0,26 -0,35 26.22% | -0,19 -0,36 46.96% | -0,20 -0,31 35.43% | -0,21 -0,28 22.64% | -0,23 -0,26 12.77% | -0,16 -0,30 46.03% | -0,19 -0,23 19.25% | -0,25 | -0,29 | -0,33 | -0,57 | -0,66 |
| Announcement Date | 03/02/22 | 10/05/22 | 04/08/22 | 13/12/22 | 07/02/23 | 09/05/23 | 08/08/23 | 12/12/23 | 13/02/24 | - | - | - | - | - |
More events
Past sector events for ESSA Pharma Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EPIX Stock
- Calendar ESSA Pharma Inc.
